Sort
40,608 grants matching “prostate cancer”
Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients
$583,281Amy Jude Hoffman · University Of Nebraska Medical Center · R01 · FY2019 · CA
Novel Hyperpolarized MR Markers of Advanced Prostate Cancer Therapy
$583,254John Kurhanewicz · University Of California, San Francisco · R01 · FY2014 · CA
Functional assessment of genes and common genetic risk variants in ovarian cancer
$583,252Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · U19 · FY2010 · CA
Protein kinase C signaling in prostate cancer health disparities
$583,194Marcelo Gabriel Kazanietz · University Of Miami School Of Medicine · R01 · FY2025 · CA
Near-Infrared Quantum Dots for In Vivo Imaging
$583,184Beth Israel Deaconess Medical Center · R33 · FY2003 · EB
A Prospective Study of Diet and Prostate Cancer
$583,177Edward Giovannucci · Harvard School Of Public Health · U19 · FY2011 · CA
TARGETING A NOVEL ANDROGEN RECEPTOR-REPRESSED PATHWAY IN PROSTATE CANCER THERAPY
$583,022University Of Pittsburgh - Of The Commonwealth System Of Higher Education · · FY2016 · Department of the Army
Defining the epigenetic landscape in human prostate cancer
$582,787Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Bringing Capacity for Theranostic Dosimetry Planning to the Nuclear Medicine Clinic
$582,748Yuni K Dewaraja · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Developmental Funds
$582,716Frank M Torti · Wake Forest University Health Sciences · P30 · FY2009 · CA
Molecular mechanisms underlying lineage plasticity in prostate cancer
$582,713Himisha Beltran · Dana-Farber Cancer Inst · R37 · FY2023 · CA
ENVIRONMENT &GLI GENES IN NORMAL DEVELOPMENT &DISEASE
$582,682Children'S Memorial Hospital (Chicago) · P01 · FY2001 · ES
Geisinger Clinical Oncology Program
$582,640Geisinger Medical Center · U10 · FY2003 · CA
The Baltimore Longitudinal Study Of Aging
$582,624Luigi Ferrucci · National Institute On Aging · ZIA · FY2009 · AG
Next-Generation Whole-Body MRI for Detection and Assessment of Therapy Response in Bone Lesions
$582,617Ananth J Madhuranthakam · Mayo Clinic Rochester · R01 · FY2025 · CA
Clinical Pharmacogenetics
$582,605William Douglas Figg · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer
$582,605William Douglas Figg · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
DECODING AND DISRUPTING THE COUPLED CELLULAR PLASTICITY AND MYELOID CELL INSTIGATION IN METASTATIC PROSTATE CANCER
$582,561University Of Notre Dame Du Lac · · FY2020 · Defense Health Agency
Cohort Study of Risks for Benign Prostatic Hyperplasia
$582,560Fred Hutchinson Cancer Research Center · R01 · FY2003 · DK
Prostate Cancer Radio-Pathomics for Differentiating Clinically Significant Disease
$582,530Peter S Laviolette · Medical College Of Wisconsin · R01 · FY2022 · CA
REGULATION AND FUNCTION OF CYTOKINES THAT PREDICT PROSTATE CANCER METASTASIS
$582,529Cedars-Sinai Medical Center · · FY2009 · Department of the Army
The Impact of FUS-Mediated Brain Cancer Therapy on BBB Transport, Cytokines, and Immunocyte Trafficking
$582,523Kim Butts Pauly · Stanford University · R01 · FY2022 · CA
Addressing Circulation of Guideline-Discordant Information to Promote Optimal Prostate Cancer Care
$582,362Stacy Loeb · New York University School Of Medicine · R01 · FY2025 · CA
Glycosylation and Immune Evasion in Urologic Tumors
$582,341Sharon Pitteri · Stanford University · U01 · FY2021 · CA
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam
$582,287John Kurhanewicz · University Of California, San Francisco · R01 · FY2010 · CA